Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_2901_Библиотеки_им_академика_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
15.09.2026
Размер:
12 Мб
Скачать
☆
218 List of Abbreviations
https://t.me/medicina_free
NSAID Nonsteroidal anti-inflammatory
drug
NSTEMI
Non-ST elevation myocardial
infarction
o.d., od, OD
Once a day
o/e On examination
OA Osteoarthritis
OGD Oesophagogastroduodenoscopy
Occupational erapist
OT
p.c. Aer food
p.m., pm, PM Aernoon or evening
p.o., po, PO Orally / by mouth / oral
administration
PTT
Partial thromboplastin time
PV Pulmonary valve
q.d.s., qds., QDS Four times a day
RCC Red cell count
ROSC Return of spontaneous circulation
RRT Renal replacement therapy
RSI Repetitive strain injuries
Road traffic accident
RTA
Rx Treatment
s.c., SC Injection under the skin
S/R Sustained release
SAH Subarachnoid haemorrhage
p.r., pr, PR
Rectally
p.r.n., prn, PRN As needed
p/c Presenting complaint
PA Postero-anterior
PaCO
Partial pressure of carbon dioxide
2
PaO2 Partial pressure of oxygen
PBC Primary biliary cirrhosis or
Primary biliary cholangitis
PCI Percutaneous coronary
intervention
PCR Polymerase chain reaction
PE Pulmonary embolism or pulmo-
nary embolus
PEG Percutaneous endoscopic
gastrostomy
physio
Physiotherapist
PIP Proximal interphalangeal joint
POP Plaster of Paris
SBP Spontaneous bacterial peritonitis
SLE Systemic lupus erythematosus
SLICC Systemic Lupus Erythematosus
International Collaborating Clinics
Speech and Language erapist
SLT
SOL Space-occupying lesion
SpR Specialist registrar
SSRI Selective serotonin reuptake
inhibitor
stat. Immediately, with no delay, now
STEMI ST-elevation myocardial infarction
t.d.s., tds., TDS ree times a day
TAV I Transcatheter aortic valve
implantation
TB
Tu berculosis
TFT yroid function test
TNF Tumour necrosis factor
PPCM Peripartum cardiomyopathy
PSC Primary sclerosing cholangitis
PT Prothrombin time
PTH Parathyroid hormone
TPMT iopurine methyltransferase
TPN Total parenteral nutrition
TRH yrotropin-releasing hormone
TSH yroid-stimulating hormone
List of Abbreviations 219
https://t.me/medicina_free
TTP rombotic thrombocytopenic purpura
TV Tricuspid valve
U&E Urea and electrolytes
UC Ulcerative colitis
UGIB Upper gastrointestinal bleed
UTI Urinary tract infection
VAT S Video-assisted thoracoscopic surgery
VEGF Vascular endothelial growth factor
Vit Vitamin
VSD Ventricular septal defect
WCC White cell count
WE Wernicke encephalopathy
WHO World Health Organization
https://t.me/medicina_free
Index
https://t.me/medicina_free
AA, see Alcoholics Anonymous ABPM, see Ambulatory blood
pressure measurements ACE inhibitor (ACEi), 24, 25 Acute coronary syndrome
(ACS),122
cardiac rehabilitation, 122, 123 coronary angiography, 122 hyperlipidaemia, 122–123 management of adult ASD, 124 NSTEMI diagnosis and
management, 121
risk factors for coronary artery
disease, 121 Adalimumab, 73 ADPKD, see Autosomal dominant
polycystic kidney disease Adrenaline, 204 AF, see Atrial fibrillation Alcoholics Anonymous (AA), 13 Alendronate, 188 Ambulatory blood pressure
measurements
(ABPM),23 Amitriptyline, 195 Angiotensin-II receptor blocker
(ARB), 24, 25 Antibiotics, 32 Anticholinergic drugs, 196 Anticoagulation, 8–10 Anti-Saccharomyces cerevisiae
antibodies (ASCA), 71 Apixaban, 10, 195 Apoplexy, 37 ARB, see Angiotensin-II receptor
blocker Asbestos-related disease, 87
ASCA, see Anti-Saccharomyces
cerevisiae antibodies
Ascitic fluid sampling/
interpretation, 130
ASD, see Atrial septal defect Aspirin, 121, 195 Asthma
ABG in acute asthma, 43 acute escalation of treatment,
44–45 severity, 44 spirometry, 45
Atorvastatin, 121 Atrial fibrillation (AF), 125
acute AF, management of,
169–170 chronic/paroxysmal AF,
management of, 170–171 treatment considerations, 125
Atrial septal defect (ASD), 123 Autosomal dominant polycystic
kidney disease
(ADPKD), 79–80 abdominal examination, 81 cyst infections, 81, 82 diagnostic criteria, 80 extra-renal manifestations of, 81 indications for nephrectomy
in, 82 nephrectomy, indications for, 82 renal manifestations of, 81 renal replacement therapy
(RRT), 82–83 screening, 81 urine dipsticks for diagnosis of
UTI in elderly, 82
Azathioprine, 62
B12 deficiencies
management, 116
symptoms, 116 Back pain, 53 Barrett’s oesophagus, 143–144 Belimumab, 62 Bell’s palsy, 152 Benzylpenicillin, 17 Betalactam, 16 BF, see Bradford Factor Biopsy, features of coeliac on, 119 Bisoprolol, 121, 195 Bisphosphonates, 188 Blatchford score, 133 Blood transfusion
complications of, 135
consent for, 134
options for patients
refusing,136
BN P, see Brain natriuretic peptide Bradford Factor (BF), 167 Breast cancer, 108
diagnosis, 107
metastatic bone pain,
management of, 109–110 osteoarthritis diagnosis, 107 risk factors, 108 screening/FHx/BRCA, 110 use of NSAIDs in elderly, 107
Breath, shortness of, 85
CA19-9, 64 Carbon monoxide poisoning
clinical indicators of, 165–166 history, 165 hyperbaric O liaison psychiatry, 167
, 166
2
221
222 Index
https://t.me/medicina_free
occupational health, 167 oxygen as prescription
medication, 167
use/prescription of oxygen/
hyperoxaemic harm,
165–166 Carcinoid tumours, 68 Cardiomyopathies, non-medical
management options
for, 199 Cavernous sinus syndrome, 39
apoplexy, 37 cranial nerves, 39–41 pituitary surgery, indications
and complications of, 38 CDAI, see Crohn’s Disease
Activity Index Cerebral lupus
mild, 62 moderate disease, 62 neurological manifestations, 62 preconception planning, 62 severe, 62 SLE criteria, 61 SLE drugs, 62 treatment of, 62
CHA
-VASc scoring system, 125
2DS2
Chemotherapy side effects, 36 Chest drain insertion,
complications of, 93–94 Chest pain, 85 Chlorphenamine, 204 Cholestatic jaundice, aetiologies
of, 63 Chronic obstructive pulmonary
disease (COPD), 95
causes of infective
exacerbations of, 98
escalation of inhalers, 97 initial investigations, 95 long-term oxygen therapy
(LTOT) criteria, 100
management of infective
exacerbations of, 98
non-invasive ventilation (NIV),
starting, 99
obstructive spirometry, 96 prophylactic antibiotics, use
of, 100
smoking cessation, 96 staging, 98 surgical options for severe
COPD, 97
Chronic thromboembolic
pulmonary hypertension
(CTEPH), 10 Ciprofloxacin, 205 Clopidogrel, 121 Clostridium difficile, 153 Clubbing, causes of, 103, 105 Coeliac disease, 115–117
causes of primary/secondary
immunodeficiency, 118
coeliac on biopsy features, 119 diagnosis of diarrhoea, 117 diagnostic/therapeutic OGD
indications, 118–119
diseases associated with, 119 food allergy history/symptoms/
testing, 119
IgA deficiency features, 117–118 symptoms and management
of iron and B12
deficiencies, 116
testing for coeliac in IgA
deficiency, 118 COPD, see Chronic obstructive
pulmonary disease Coronary angiography, 122–123 Coronary artery disease, risk
factors for, 121 Cough, 95 Cranial nerves, 39, 40
recovery of cranial nerve
palsies, 41 Crohn’s disease, 71, 73 Crohn’s Disease Activity Index
(CDAI), 73 CTEPH, see Chronic
thromboembolic
pulmonary hypertension Cushing’s reflex, 127 Cyclophosphamide, 62
DAFNE course, see Dose
Adjustment for Normal
Eating course Delirium, 194–195
vs. dementia, 195
Demyelinating neuropathy,
features of, 56 Demyelination, 3 Depression, diagnostic criteria
for, 159 De Quervain’s thyroiditis, 21
abnormal TFTs, 19, 20 Dexamethasone, 2 Diabetes insipidus (DI), 177 Diabetes insipidus, diabetes
mellitus, optic atrophy and deafness (DiDMOAD), 113
Diarrhoea, diagnosis of, 117 DiDMOAD, see Diabetes
insipidus, diabetes mellitus, optic atrophy
and deafness DOACs, 10 Dose Adjustment for Normal
Eating (DAFNE)
course,190 DRABCDE management, 8, 132 Duke criteria, 16 Dysdiadokokinesia, 11 Dyspepsia, 139
Barrett’s surveillance, 143–144 explaining sedation, 142–143
H. pylori
eradication therapy, 141 testing, 140–141 hiatus hernia, types of, 142 lifestyle changes, 139–140 management of dysplasia, 144 management of non-specific
dyspepsia, 141
medication review, 140 oesophagogastroduodenoscopy
(OGD) risks, when
consenting, 142
pathophysiology, 143 red flag symptoms, 139
Eczema, finding of, 43 Empyema, 93 End-stage renal failure (ESRF), 80 ERCP
complications, 66
Index 223
https://t.me/medicina_free
indications, 65–66
Esomeprazole, 141 ESRF, see End-stage renal failure
Facial nerve palsy
and Bell’s palsy, 152 differential diagnoses for, 152 management of, 152
Familial hypercholesterolaemia
(FH), 123 Febrile neutropenia, 32 Fever in returning traveller, 147
CNVII palsy, 151 differential diagnosis in
returning traveller,
147–150
Lyme disease testing, 147–150 meningitis causes, 146 notifiable diseases, 150 pseudomembranous colitis, 153 red flags clinical signs of
meningitis, 145
travel history, 146–147
FH, see Familial
hypercholesterolaemia Fidaxomin, 153 Fingers, pain and stiffness
in, 207 Fluoroquinolone prophylaxis, 36 Fondaparinux, 121 Furosemide, 195
Gardner’s syndrome, 69 Gastrinoma, 67 G-CSF indications and side
effects,33 Geneva score, 8 Gentamicin, 17 Geriatrics
anticholinergic drugs, 196 delirium, 194–195 discharge planning, 195–196 falls, 193, 196
Giant cell arteritis, diagnostic
criteria for, 185 Glasgow score, 67 Glucagonoma, 67 Glucocorticoids, 2 Guillain–Barré syndrome
autonomic dysfunction, signs
and testing of, 54–55 causes, 55, 56 differential diagnoses for
peripheral neuropathy, 54 investigations for, 55 management of, 56 nerve conduction studies, 55 neuropathic pain, causes of, 58 spirometry, 55–57 upper vs. lower MN signs, 54
Haemodynamic stability, 8 HASBLED scoring system, 125, 126 HbA1c value, 3 HBPM, see Home blood pressure
measurements
Headache
differential diagnosis of, 183 ‘red flag’ headache, 184
Helicobacter pylori
eradication therapy, 141 testing, 140–141
Heparin-induced
thrombocytopenia
(HIT), 112 causes of thrombocytopenia, 112 diabetic ulcers, 112 diagnosis of, 113 hearing loss in DM, 111, 113 high-penetrance genetic
diseases, 113–114 importance of, 112–113 treatment of, 113
Hepatobiliary cancer, 64 Hepatorenal syndrome (HRS), 137
management of, 137 types of, 137
Herpes simplex encephalitis, 50
autoimmune encephalitis, 50 causes of, 50 clinical outcome of HSV
encephalitis, 51 differential diagnoses for
confusion/drowsiness, 47 imaging in HSV encephalitis, 49 LP interpretation, 48 management of HSV
encephalitis, 51
neuro-rehabilitation, 51
HHS, see Hyperglycaemic
hyperosmolar state Hiatus hernia, types of, 142 High-risk neutropenia
prophylaxis, 36 HIT, see Heparin-induced
thrombocytopenia HIV seroconversion
differential diagnosis of acute
HIV infection, 156
HIV drug treatments, 157 post-exposure prophylaxis
(PEP), 155
preventing transmission of
HIV, 156
seroconversion illness, 156
Home blood pressure
measurements
(HBPM),23 HRS, see Hepatorenal syndrome Hydrocortisone, 204 Hydrocortisone replacement, 39 Hydroxychloroquine, 62 Hyperbaric oxygen, 166 Hypercalcaemia, 88, 179
causes of, 88, 180 differential diagnoses of, 180 management, 88 reproductive system alteration
in sarcoidosis, 181
sarcoid, 180 symptoms of, 88 testosterone treatments, 181
Hyperglycaemic hyperosmolar
state (HHS), 176
bariatric management, 176 criteria and management of,
176, 177
diabetes prevention, 175, 178 hypernatremia, 177 role of inpatient diabetes
teams, 177
treatment plan, 176 Hyperkalaemia, 35 Hyperlipidaemia, 122–123 Hypernatremia, 177 Hyperphosphataemia, 35 Hypertension, 24
224 Index
https://t.me/medicina_free
ambulatory/home monitoring
and white coat
hypertension, 23 dietary and lifestyle advice, 24 management, including
medications and targets,
24, 25 resistant hypertension, 25 secondary causes of, 59 stage 1 hypertension, 24 treatment, 24 white coat hypertension, 23
Hypertensive retinopathy, 23, 25
management of, 25 signs of, 25
Hyperthyroidism, 19 Hypertonic saline, 28 Hyperuricaemia, 35 Hypocalcaemia, 35 Hypoglycaemia and driving, 189
differential diagnosis, 189–190 driving rules, 189 hypoglycaemic awareness, 189,
190, 191 insulin pumps, 191
Hyponatraemia, 27, 29
drugs associated with, 28 key investigations in, 28 management, 27 osmotic demyelination
syndrome, 29
prognosis of, 30
rate of correction of, 30
IBD, see Inflammatory bowel
disease
Ibuprofen, 107 ICDs, see Implantable cardioverter
defibrillators
Idiopathic pulmonary fibrosis, see
Pulmonary fibrosis
Idiopathic transverse myelitis, see
Transverse myelitis
IgA deficiency
features of, 117–118 testing for coeliac in, 118
Implantable cardioverter
defibrillators (ICDs), 173
Infective endocarditis, 15, 17
complications of, 18 diagnosis of, 15 Duke criteria, 15, 16 management, 17 transcatheter aortic valve
implantation (TAVI), 17
Inflammatory arthritis, testing
and referring for, 207
Inflammatory bowel disease
(IBD),72 disease severity, 73 extra-intestinal
manifestations,72 investigations, 71 medications for, 73, 74 refeeding syndrome risk factors
and avoidance, 77 short bowel syndrome, 76 toxic megacolon
diagnostic criteria, 75
management, 76 Infliximab, 73 Insulinoma, 67 Insulins used in type 1
diabetes,191 Intention tremor, 11 Iron deficiencies
management, 116 symptoms, 117
Jalan criteria, 75 Jaundice, 63 Joint aspiration, consenting for, 204
Knee pain, 201 Korsakoff syndrome, 13
Lactic acidosis, types and causes
of, 162 Lansoprazole, 141 Laxido, 195 Legs, weakness in, 1 Levothyroxine, 195 Lhermitte’s phenomenon, 3 Li–Fraumeni syndrome, 69 Light’s criteria, 92 Liver transplantation
complications of, 163–164 criteria, 162
Long-term oxygen therapy
(LTOT), 100
Lumbar puncture, 48 Lupus, see Cerebral lupus Lyme disease, 150
testing, 147
Lynch syndrome, 69
Malignant middle cerebral artery
(MCA) syndrome, 127
Mamillary body atrophy,
significance of, 12
Massive PE (pulmonary
embolus),9 anticoagulation, 8–10 DOACs, 10 DRABCDE approach, 8 Geneva score, 8 long-term implications of
having, 10 recurrence of, 9
Maternally inherited diabetes and
deafness (MIDD), 113
MCA syndrome, see Malignant
middle cerebral artery
syndrome
Meningitis
key causative organisms
of, 146 red flag clinical signs of, 145
Mesothelioma, 86, 87
asbestos-related disease, 86 atypical pneumonia, 85–86 breaking bad news, 87–88 death confirmation, 90 hypercalcaemia, 88 occupational history, 86 palliative discharge, 89 pleural plaques, 86, 87
Metastatic bone pain, management
of, 109–110
Metformin, 195 Methotrexate, 62
and lithium, in women of
childbearing age, 212 monitoring, 211 prescribing considerations, 211
Methylprednisolone, 2 Metronidazole, 153
Index 225
https://t.me/medicina_free
MIDD, see Maternally inherited
diabetes and deafness Minus 2 rule, 3 Montelukast, 45 MRCP
advantages of, 65 disadvantages of, 65 indications, 65
Multiple endocrine neoplasia type
1, 69 Multiple sclerosis, 3
risk of, 4
Mycophenolate mofetil, 62
National Early Warning Score, see
NEWS Neck, sore, 19 Neuropathic pain, causes of, 58 Neutropenic sepsis, 32
causes of neutropenia, 32–33 chemotherapy side effects, 36 G-CSF indications and side
effects, 33
high-risk neutropenia
prophylaxis, 36
Sepsis 6 protocol, 31, 33 sepsis red flags, 31 tumour lysis syndrome
diagnosis/symptoms/
management, 33–35 NEWS, 31, 56, 99NIV, see Non-
invasive ventilation Non-invasive ventilation (NIV), 99 Non-malignant disease, pallative
care in, 106 Nonsteroidal anti-inflammatory
drug, 62 Noradrenaline, 8 Nosebleed, 205 NSAIDs, 107 NT-proBNP, 197–198
factors affecting levels of, 198 testing, 198
Oesophagogastroduodenoscopy
(OGD), 139, 142 Omalizumab, 45 Omeprazole, 141 Optimised standard therapy, 45
Osmotic demyelination
syndrome,29
prognosis of, 30
Osteoporosis, risk factors for, 187
Palliative discharge, medications
for, 89
Palpation, renal enlargement on, 79 p-ANCA, see Perinuclear
antineutrophil cytoplasmic antibodies
Pancreatic cancer, 64, 68, 69
aetiologies of cholestatic
jaundice, 63 ERCP complications, 66 ERCP/MRCP indications, 65 familial cancer syndromes, 68 genetic history taking, 68 Glasgow score, 67 insulinoma diagnosis, 67 pancreatic neuroendocrine
symptoms, 67, 68 tumour markers, 64
Pantoprazole, 141 Paracetamol overdose
depression criteria and
management, 159–160 features of high risk
overdose,161 first- and second-line options
for treatment, 160 lactic acidosis, types of, 162 liver transplantation
complications of, 163–164
criteria, 162 management, 160 poisoning history, 160 suicide risk assessment, 160–161
Parapneumonic effusion, 92 Perinuclear antineutrophil
cytoplasmic antibodies (p-ANCA), 71
Peripartum cardiomyopathy
(PPCM), 198 abnormal LFTs, 197 NT-proBNP testing, 198 contraception options in, 199 pre-eclampsia, 198 recovery from, 199
Peripheral neuropathy, differential
diagnoses for, 54
Permanent pacemaker insertion,
indications for, 173 Peutz–Jeghers syndrome, 69 Pituitary surgery, indications and
complications of, 38 Plasmapheresis, 2 Pleural effusion
chest drain insertion,
complications of, 93, 94
interpretation of pleural
aspiration, 92
Light’s criteria, 92 management of, 93 parapneumonic effusion
andempyema,
management of, 92 Pleural plaques, 86, 87 Pneumonia, atypical, 85–86 Pneumothorax
management of, 173–174 signs of, 173
Postural hypotension, major
causes of, 196 PPCM, see Peripartum
cardiomyopathy Prednisone, 62 Pseudogout
anaphylaxis management and
avoidance, 204
joint aspiration, consenting
for, 204
joint aspiration interpretation,
203, 204
management of gout and
pseudogout, 202
osteoarthritis vs. gout vs.
pseudogout, 201
septic arthritis, 204, 205 warfarin interactions and
management of bleed on
warfarin, 201, 205 Pulmonary embolus, see
MassivePE Pulmonary fibrosis, 103
anatomical/severity markers on
HRCT, 103
clubbing, causes of, 103, 105
226 Index
https://t.me/medicina_free
drugs for idiopathic pulmonary
fibrosis, 103
pallative care in non-malignant
disease, 106
Raloxifene, 188 Ramipril, 121, 195 Ranitidine, 141 Rash, 71 ‘Red flag’ headache, 184 Refeeding syndrome risk factors
and avoidance, 77
Renal enlargement on palpation,
differential diagnosis for, 79
Renal replacement therapy (RRT),
82, 83 Resistant hypertension, 25 Returning traveller, fever in,
see Fever in returning
traveller Rheumatoid arthritis, 207
contraception choices, 213 DAS28 scoring in, 211 inflammatory arthritis, testing
and referring for, 207
lithium interactions, 210 lithium toxicity diagnosis and
management, 208–209
methotrexate and lithium in
women of childbearing
age, 212
methotrexate monitoring, 211 methotrexate prescribing
considerations, 211
seronegative disease, 208 Rivaroxaban, 10 Rockall score, 133 RRT, see Renal replacement
therapy
Sarcoidosis
organ-based manifestations
of, 180
reproductive assessment in, 181 SBP, see Spontaneous bacterial
peritonitis
Selective serotonin reuptake
inhibitors (SSRIs), 160
Senna, 195 Sepsis 6 protocol, 31, 33 Sepsis red flags, 31 Seronegative rheumatoid arthritis,
208 Short bowel syndrome, 76 Sodium chloride, 204 Somatostatinoma, 68 Spirometry, 45, 55–57 Spontaneous bacterial peritonitis
(SBP), 131 SSRIs, see Selective serotonin
reuptake inhibitors Steroid, 3 Steroid regimes and weaning, 185 Strep viridans, 15 Stroke, 125
blood pressure monitoring in
acute management of,
126–127
CHA
-VASc and HASBLED
2DS2
scores, 125, 126
haemorrhagic transformation,
126, 127
management of, 126–127 thrombolysis, 125, 126
TAV I, see Transcatheter aortic
valve implantation Temporal arteritis, 185
extra-pyramidal side effects, 186 fracture risk assessment and
BMD score, 187
giant cell arteritis (GCA),
diagnostic criteria
for,185
headache, differential diagnosis
of, 183
mental state exam, 185–186 osteoporosis, risk factors
for,187
‘red flag’ headache, 184 second-generation (atypical)
antipsychotics, 186
steroid regimes and
weaning,185 Tension pneumothorax, 173–174 Testicular size, assessing, 179 Testosterone treatments, 181
TFT abnormalities, see
yroid function test abnormalities
iazide-like diuretic (TLD),
24,25 oracocentesis, 174 rombocytopenia, common
causes of, 60 rombolysis, 9 yroid function test (TFT)
abnormalities, 19, 20 yroid-stimulating hormone
(TSH), 19–21 yroxine treatment, 21 TLD, see iazide-like diuretic Toxic megacolon
diagnostic criteria, 75–76 management, 76
Transcatheter aortic valve
implantation (TAVI), 17 Transketolase, 11 Transoesophageal
echocardiogram, 17 Transverse myelitis, 2
diagnostic criteria, 2 differential diagnoses, 4 Lhermitte’s phenomenon, 3 multiple sclerosis, risk of, 4 prognosis of, 3 recurrence of, 3 steroid, 3
TSH, see yroid-stimulating
hormone Tumour lysis syndrome diagnosis/
symptoms/management,
33, 34
prophylaxis given for, 35
Type 1 diabetes
glycaemia in, 190–191 insulins used in, 191
Unconsciousness, 7 Urine dipsticks for diagnosis of
UTI in elderly, 82
Vancomycin, 16, 153 Variceal bleed, 137
ascitic fluid sampling/
interpretation, 130
Index 227
https://t.me/medicina_free
blood transfusion consent, 134 differential diagnosis of
ascites,129 DRABCDE management, 132 hepatorenal syndrome (HRS)
management of, 137
types of, 137 Rockall/Blatchford scoring, 133 spontaneous bacterial
peritonitis (SBP), 131
transfusion reactions/
complications, 135
use of blood products, 135
Vasopressor therapy, 8 Vedolizumab, 73 VIPoma (vasoactive intestinal
polypeptide secreting tumours), 68
Von Hippel–Lindau syndrome, 69
Walking, difficulty in, 1 Warfarin, 10, 205 Wellens’ syndrome, 172
acute atrial fibrillation,
management of, 169–170
chronic/paroxysmal atrial
fibrillation, management
of, 170–171 diagnostic criteria, 172 implantable cardioverter
defibrillators (ICDs),
indications for, 173 permanent pacemaker
insertion, indications
for, 173
pneumothorax, management
of, 173–174 pneumothorax, signs of, 173 significance, 172 tension pneumothorax,
management of, 174
Wells’ score, 8 Wernicke’s encephalopathy, 11
alcohol withdrawal, 11 chronic neurological
conditionas a
consequence of, 13 classic triad of, 12 community follow-up/
support,13 potential complications of, 12
White coat hypertension, 23